| | |
ASPsiRNA information |
siRNA Id: | aspsirna0880
|
siRNA Name: | K6a_513a.5
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | UAGUUCUGGGAGUUGUUGU
|
ASP-siRNA (As strand 3'->5'): | UAGUUCUGGGAGUUUUUGU
|
Mismatch position in siRNA: | U5C |
Gene Information |
Gene Name | Keratin 6a (KRT6a) |
Target Sequence (5'->3'): | AACAGATCAAGACCCTCAACAACAAGTTTGCCTC
|
Wild allele (5'->3'): | AUCAAGACCCUCAACAACA
|
Mutant allele (5'->3'): | AUCAAGACCCUCAAAAACA
|
Position of siRNA on target gene: | 718-736
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_005554.3 |
Cytogenic location: | 12q13.13 |
Chromosomal coordinates: | 12:52,880,957-52,887,180 |
UniProt ID: | P02538 |
HUGO ID: | 6443 |
Reference SNp(RefSNP): | rs59685571 |
Disease/Mutation information |
Target Mutation: | c.513C>A,p.Asn171Lys
|
Matation type/variant: | Single nucleotide variant/Missense variant
|
Mutation at gene level: | NG_008298.1:g.5722C>A
|
Pathogenic status of mutation: | Disease causing N171K mutation in K6a gene
|
Disease: | Pachyonychia congenita (PC) |
Clinical Resources |
ClinVar ID: | 66589 |
KEGG disease ID: | H00684 |
OMIM ID: | 167200 |
COSMIC: | KRT6a |
DECIPHER: | KRT6a |
GeneTests: | KRT6a |
ASP siRNA details |
Mutant allele (5'->3'): | AUCAAGACCCUCAAAAACA
|
ASP-siRNA (As strand 3'->5'): | UAGUUCUGGGAGUUUUUGU
|
Percentage efficacy of ASP-siRNA for mutant allele: | 67
|
Wild allele (5'->3'): | AUCAAGACCCUCAACAACA
|
ASP-siRNA (As strand 3'->5'): | UAGUUCUGGGAGUUUUUGU
|
Percentage efficacy of ASP-siRNA for wild allele: | 39
|
Relative difference: | 28
|
Wild siRNA details |
Wild allele (5'->3'): | AUCAAGACCCUCAACAACA
|
Wild siRNA (As strand 3'->5'): | UAGUUCUGGGAGUUGUUGU
|
Percentage efficacy of wild siRNA for wild allele: | 46
|
Wild allele (5'->3'): | AUCAAGACCCUCAACAACA
|
ASP-siRNA (As strand 3'->5'): | UAGUUCUGGGAGUUUUUGU
|
Percentage efficacy of Wild sirna for mutant allele: | 12
|
Relative difference : | 34
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA
|
Cell-line used: | 293T |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Dharmacon |
Post-transfection duration: | 48 hours |
Concentration used: | 150ng |
Reference: | 17914454 |
Delivery method: | Transfection |
Article title: | Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. |
Authors: | Hickerson RP, Smith FJ, Reeves RE, Contag CH, Leake D, Leachman SA, Milstone LM, McLean WH, Kaspar RL. |
Journal Reference: | J Invest Dermatol. 2008 Mar;128(3):594-605. Epub 2007 Oct 11. |